Skip to content
GLP-1 Desk
Menu
Dispatch #10Editorial

BetterMe Rx

Mid-market pricing with oral options and 50-state coverage inside a habit-focused app.

Visit BetterMe RxEditorial — no commercial relationship.
Semaglutide
$199/mo
Tirzepatide
$299/mo
Coverage
All 50 states
Brand-name
Compounded only

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency84/100
State access96/100
Molecule range90/100
Onboarding speed82/100
Support responsiveness80/100
Licensing & trust88/100

What the Desk likes

  • Oral and injectable routes available
  • Nationwide 50-state coverage
  • Familiar app-based experience

Where points come off

  • Tirzepatide priced above the value leaders
  • No brand-name access

The Desk's briefing — B

Best for: App-first users who want oral options and nationwide access with built-in coaching cues.

BetterMe Rx ranks #10 of 25 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Pricing and verification reflect BetterMe Rx's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on BetterMe Rx's site. Not medical advice; see our disclosure.

← Back to The Desk